Ross, L <br/><br/>
Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia.  [electronic resource] 

 -  AIDS (London, England)  May 2000 
 - 813-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-200005050-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-HIV Agents--therapeutic use<br/>Codon<br/>Cohort Studies<br/>Drug Resistance, Microbial--genetics<br/>Drug Therapy, Combination<br/>Genetic Variation<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV Protease--genetics<br/>HIV Reverse Transcriptase--genetics<br/>HIV-1--enzymology<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Phenotype<br/>RNA, Viral--blood<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Viremia--virology